Bionano Genomics Cash Flow Statement (2017-2026) | BNGO

Cash Flow Statement Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-18.79M-20.75M-22.95M-29.95M-32.16M-31.81M-38.68M-37.12M-38.91M-112.57M-43.89M-31.42M-16.22M-44.25M-20.56M-3.10M-6.86M-8.50M-7.93M-8.30M
Depreciation and Depletion (Quarter)
-0.50M5.40M1.10M-1.10M1.00M
Share-based Compensation (Quarter)
1.76M2.79M-4.90M5.10M5.78M6.06M5.48M3.88M3.93M3.99M3.37M3.02M2.58M2.20M1.94M1.59M1.08M0.94M0.93M0.67M
Gains from Sales and Divestitures (Quarter)
0.00M360.00
Gains from Investment Securities (Quarter)
2.31M-2.24M0.02M0.50M-0.48M0.02M-0.04M-1.44M-0.28M0.27M-1.40M-1.44M-0.33M0.33M-0.26M0.33M0.02M
Asset Writedowns and Impairment (Quarter)
0.62M0.40M7.20M-0.40M
Non-cash Items (Quarter)
0.13M
Cash from Operations (Quarter)
-12.42M-19.98M-25.62M-32.49M-28.33M-29.47M-34.52M-32.41M-36.70M-26.29M-29.78M-28.13M-20.98M-13.31M-6.50M-2.76M-3.54M-5.90M-4.14M-5.72M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
77.30M
Amortizatization of Intangibles (Quarter)
0.02M0.03M-0.58M-0.14M0.06M0.05M0.05M0.05M0.05M0.69M0.22M0.26M0.14M0.24M0.25M0.24M0.25M0.05M
Amortization of Deferred Charges (Quarter)
0.07M-0.20M
Depreciation & Amortization (CF) (Quarter)
0.52M0.53M1.86M2.21M2.27M2.38M2.77M3.19M3.30M3.62M3.60M3.01M2.29M2.29M2.40M2.43M1.81M1.77M2.34M2.31M
Change in Working Capital
Change in Receivables (Quarter)
0.85M0.27M0.16M0.64M-0.66M1.16M1.12M-0.24M0.83M1.06M0.65M-1.00M-2.06M-0.94M-0.13M-1.40M0.14M1.03M0.67M-1.07M
Change in Inventory (Quarter)
2.64M6.74M5.58M5.94M6.16M6.03M5.55M5.71M1.64M-3.53M0.33M0.20M0.87M2.45M-2.93M-1.11M-0.72M-1.51M-1.57M0.11M
Change in Account Payables (Quarter)
1.86M4.13M1.84M-3.17M1.09M0.84M3.18M3.02M-3.81M3.19M-4.40M-0.54M-1.11M-0.03M-1.74M-0.40M-0.32M-0.25M-0.40M-0.53M
Change in Accured Expenses (Quarter)
2.13M3.02M-0.14M-0.44M-1.03M3.54M-1.70M-0.98M-1.09M3.04M-3.49M3.17M-5.25M0.39M-0.55M-0.49M-1.33M0.72M0.52M-1.42M
Other Working Capital Changes (Quarter)
-1.45M2.47M-0.75M0.05M0.04M3.30M-0.19M0.37M-2.16M0.41M6.40M-0.79M-0.34M0.79M-1.24M-0.07M-0.59M2.90M-0.17M-0.34M
Investing Activities
Capital Expenditures (Quarter)
0.83M0.25M-0.22M-0.77M0.23M-0.13M0.84M0.74M0.03M0.08M
Sales of Property, Plant and Equipment (Quarter)
0.13M-0.13M0.03M-0.00M
Acquisitions (Quarter)
49.09M-0.69M32.04M
Change in Acquisitions & Divestments (Quarter)
20.00M66.48M47.18M46.30M41.91M65.50M16.89M29.99M37.99M52.15M158.17M69.74M57.36M21.70M50.70M53.85M56.22M68.36M54.13M
Cash from Investing Activities (Quarter)
0.07M-185.60M-92.51M31.96M31.24M7.95M11.61M16.53M29.58M33.43M-55.37M47.59M28.63M-5.38M3.00M-14.07M1.98M-4.67M4.01M5.46M
Financing Activities
Other financing activities (Quarter)
0.32M0.56M0.58M0.38M0.46M0.32M0.28M0.39M0.98M0.08M0.30M0.92M0.10M-1.02M2.12M0.03M
Cash from Financing Activities (Quarter)
-17.16M13.77M1.97M0.01M0.20M22.65M0.15M14.86M17.88M12.59M68.48M-21.62M-1.98M6.02M3.89M10.89M1.47M10.08M1.60M0.66M
Additional items
Exchange Rate Effect (Quarter)
-0.12M0.09M0.04M-0.01M-0.01M0.05M-0.03M-0.00M0.02M-0.00M-0.01M-0.02M0.01M0.01M0.01M
Change in Cash (Quarter)
-29.50M-191.82M-116.17M-0.52M3.11M1.01M-22.68M-0.99M10.75M19.71M-16.62M-2.19M5.67M-12.64M0.38M-5.95M-0.06M-0.50M1.44M0.40M
Free Cash Flow (Quarter)
-12.42M-19.98M-25.62M-33.33M-28.58M-29.25M-33.75M-32.64M-36.57M-27.14M-30.52M-28.16M-21.05M-13.31M-6.50M-2.76M-3.54M-5.90M-4.14M-5.72M
Net Cash Flow (Quarter)
-29.50M-191.82M-116.17M-0.52M3.11M1.13M-22.76M-1.02M10.76M19.72M-16.67M-2.16M5.67M-12.66M0.38M-5.94M-0.09M-0.49M1.47M0.40M